ScholarIQanswers from OpenAlex

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors

PaperCitations, authors & open-access status

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors have?

ScholarIQcitation count

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors has 29 citations in the OpenAlex counts ScholarIQ stores.

When was Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors published?

ScholarIQyear

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors has 2023 year in the ScholarIQ index.

What is the open-access status of Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

ScholarIQoa status

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors has gold oa status in the ScholarIQ index.

What is the DOI of Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

ScholarIQdoi

The DOI for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is on the source record.

What is the PMID of Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

ScholarIQpmid

The PMID for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is on the source record.

What is the OpenAlex record for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

ScholarIQopenalex

The OpenAlex for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial